Lifitegrast
لیفیتگراست
👁️ Sensory OrgansLFA-1 antagonist (ophthalmic)
Market / country: 🇺🇸 USA
Xiidra (US)
🧮 Dose calculator
Dry eye · Regimen source: FDA Xiidra · 2
- • Discard the single-use container after use; remove contact lenses before and reinsert 15 min after. FDA Xiidra · 2
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to lifitegrast. FDA Xiidra · 4
Formulations
- 5% (50 mg/mL) single-use containers — eye drops 🇺🇸 USA FDA Xiidra · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Xiidra · 8.1
“Risk Summary There are no available data on Xiidra use in pregnant women to inform any drug-associated risks.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Xiidra · 8.2
“Risk Summary There are no data on the presence of lifitegrast in human milk, the effects on the breastfed infant, or the effects on milk production.”
- 👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA Xiidra · 8.4
“Safety and efficacy in pediatric patients below the age of 17 years have not been established.”
- 👴 Older adultsNo specific problem stated
Label: no specific difference or dose adjustment stated for older adults. FDA Xiidra · 8.5
“No overall differences in safety or effectiveness have been observed between elderly and younger adult patients.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)NDA208073
- DailyMed (FDA label)FDA Xiidra
- MedlinePlus (NIH)Lifitegrast Ophthalmic
- WHO ATC/DDDS01XA25
- Darooyab (Iran)❌ None
🇮🇷 Not found in Iran list Darooyab · search
Darooyab lists no registered dosage form or brand for this drug. This does not prove it is unavailable.
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Xiidra · 3FDA Xiidra · 2FDA Xiidra · 4FDA Xiidra · SPL approval / marketing categoryFDA Xiidra · 8.1FDA Xiidra · 8.2FDA Xiidra · 8.4FDA Xiidra · 8.5
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · search
- Clinical review⚠ Unverified